We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 348

State Attorneys General Vigilant on Price Gouging Following Hurricanes Harvey and Irma
  • Jones Day
  • USA
  • September 10 2017

Many states have prohibitions on price gouging that go into effect during states of emergency. In this hurricane season, seven U.S. states and


Democrats Seek Overhaul of Antitrust Merger Review with "Better Deal" Proposal
  • Jones Day
  • USA
  • August 31 2017

Democrats in Congress have proposed legislation that would rewrite U.S. antitrust law, expanding the criteria antitrust


DOJ Obtains Price-Fixing Guilty Plea from E-Commerce Company and Top Executive
  • Jones Day
  • USA
  • August 23 2017

The U.S. Department of Justice recently announced that an e-commerce company and its president have agreed to plead guilty to participating in a


"Better Deal" Legislative Proposal Would Overhaul U.S. Antitrust Merger Review
  • Jones Day
  • USA
  • August 12 2017

Proposed legislation would rewrite U.S. antitrust law, expanding the criteria antitrust agencies would be required to use to evaluate proposed


DOJ Antitrust Corporate Dispositions May Protect Some Culpable Employees
  • Jones Day
  • USA
  • August 7 2017

Corporate plea agreements can eventually resolve liability for most companies under investigation by the U.S. Department of Justice's Antitrust


Antitrust Alert: Federal Court Rejects Failing Firm Defense in Merger Case
  • Jones Day
  • USA
  • July 21 2017

A new decision from a federal court in Delaware reinforces the high burden that parties face in insulating an otherwise anticompetitive merger based


Supreme Court: Biosimilar Applicants May Provide Commercial Marketing Notice Before FDA Approval
  • Jones Day
  • USA
  • June 21 2017

Intended to provide a faster route to approval for generic biologics, the Biologics Price Competition and Innovation Act, was the basis for a


DOJ-Antitrust Revises Guidance on Coverage of "Current" Employees in Company Leniency Agreements
  • Jones Day
  • USA
  • May 10 2017

DOJ has historically offered protection to the current employees of companies that have applied for Type B leniency, even if


Use It or Lose It: USPTO to Conduct Post-Registration Trademark Use Audits
  • Jones Day
  • USA
  • March 23 2017

The United States Patent and Trademark Office ("USPTO") may now issue post-registration Office actions requiring evidence of use


FTC Merger Remedies Report Signals Tougher Enforcement
  • Jones Day
  • USA
  • February 15 2017

The Federal Trade Commission staff have completed a new study evaluating its process for designing and implementing merger remedies and the success